203 related articles for article (PubMed ID: 38476610)
1. Prognostic biomarker CPEB3 and its associations with immune infiltration in clear cell renal cell carcinoma.
Hong H; Shi X; Ou W; Ou P
Biomed Rep; 2024 Apr; 20(4):63. PubMed ID: 38476610
[TBL] [Abstract][Full Text] [Related]
2. ARHGAP11A Is a Novel Prognostic and Predictive Biomarker Correlated with Immunosuppressive Microenvironment in Clear Cell Renal Cell Carcinoma.
Yang H; Zhang H; Zhang L; Tusuphan P; Zheng J
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175461
[TBL] [Abstract][Full Text] [Related]
3. NUDT1 Could Be a Prognostic Biomarker and Correlated with Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Lin Y; Zhang F; Jin Y; Zhong Q; Tan W; Liu J; Wu Z
Appl Bionics Biomech; 2022; 2022():3669296. PubMed ID: 36606241
[TBL] [Abstract][Full Text] [Related]
4. POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Tian J; Cheng C; Gao J; Fu G; Xu Z; Chen X; Wu Y; Jin B
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047824
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma.
Stenzel PJ; Schindeldecker M; Tagscherer KE; Foersch S; Herpel E; Hohenfellner M; Hatiboglu G; Alt J; Thomas C; Haferkamp A; Roth W; Macher-Goeppinger S
Transl Oncol; 2020 Feb; 13(2):336-345. PubMed ID: 31881506
[TBL] [Abstract][Full Text] [Related]
6. The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma.
Monjaras-Avila CU; Lorenzo-Leal AC; Luque-Badillo AC; D'Costa N; Chavez-Muñoz C; Bach H
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175653
[TBL] [Abstract][Full Text] [Related]
7.
Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene B4 receptor 2 correlates with prognosis and immune infiltration in clear cell renal cell carcinoma.
Yuan X; He Y; Luo C; Wang W
Invest New Drugs; 2022 Apr; 40(2):232-244. PubMed ID: 34633577
[TBL] [Abstract][Full Text] [Related]
9. SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.
Xu Z; Wu Y; Fu G; Chen X; Sun J; Tian J; Jiang P; Wang Y; Jin B
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108666
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of alternative polyadenylation regulators of CTLA4 and immune infiltration in clear cell renal cell carcinoma.
Zhou M; Long W; Xiong M; Zhang F; Chen L; Chen J; Pang Z; Hou T; Li W
Transl Androl Urol; 2023 Apr; 12(4):533-548. PubMed ID: 37181233
[TBL] [Abstract][Full Text] [Related]
11. Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma.
Wang Q; Tang H; Luo X; Chen J; Zhang X; Li X; Li Y; Chen Y; Xu Y; Han S
Front Immunol; 2022; 13():890150. PubMed ID: 35686121
[TBL] [Abstract][Full Text] [Related]
12. Upregulated X-C motif chemokine ligand 2 (XCL2) is associated with poor prognosis and increased immune infiltration in clear cell renal cell carcinoma.
Cao Q; Liu D; Chen Z; Wang M; Wu M; Zeng G
Cell Signal; 2023 Feb; 102():110556. PubMed ID: 36503163
[TBL] [Abstract][Full Text] [Related]
13. Immune inactivation by CD47 expression predicts clinical outcomes and therapeutic responses in clear cell renal cell carcinoma patients.
Jiang W; Zeng H; Liu Z; Jin K; Hu B; Chang Y; Liu L; Zhu Y; Xu L; Wang Z; Guo J; Xu J
Urol Oncol; 2022 Apr; 40(4):166.e15-166.e25. PubMed ID: 34998671
[TBL] [Abstract][Full Text] [Related]
14. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures.
Şenbabaoğlu Y; Gejman RS; Winer AG; Liu M; Van Allen EM; de Velasco G; Miao D; Ostrovnaya I; Drill E; Luna A; Weinhold N; Lee W; Manley BJ; Khalil DN; Kaffenberger SD; Chen Y; Danilova L; Voss MH; Coleman JA; Russo P; Reuter VE; Chan TA; Cheng EH; Scheinberg DA; Li MO; Choueiri TK; Hsieh JJ; Sander C; Hakimi AA
Genome Biol; 2016 Nov; 17(1):231. PubMed ID: 27855702
[TBL] [Abstract][Full Text] [Related]
15.
Cheng X; Sun D; Li H; Zhang J; Luo Q; Jin X; Chen Y; Yuan Q; Wang B
Transl Androl Urol; 2023 Apr; 12(4):642-658. PubMed ID: 37181237
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of the role of CXCL family members in clear cell renal cell carcinoma.
Qiu J; Wang Z; Zhang P; Xu Y; Yang T; Xia Q
Curr Cancer Drug Targets; 2023 Aug; ():. PubMed ID: 37641996
[TBL] [Abstract][Full Text] [Related]
17. ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma.
Shao Y; Wu B; Yang Z; Liu Z; Ma Y; Huang H; Liu Y; Wang Z; Hu W; Wang Y; Niu Y
Transl Androl Urol; 2023 Apr; 12(4):549-571. PubMed ID: 37181232
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma.
Zhang H; Liu Y; Wang B; Wang C
BMC Genom Data; 2022 Jul; 23(1):58. PubMed ID: 35883015
[TBL] [Abstract][Full Text] [Related]
19. Decreased Expression of CPEB3 Predicts a Poor Prognosis in Patients with Melanoma: A Study Based on TCGA Data.
Zhang X; Liang Y
Biomed Res Int; 2021; 2021():8197936. PubMed ID: 33506034
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion.
Fu Q; Xu L; Wang Y; Jiang Q; Liu Z; Zhang J; Zhou Q; Zeng H; Tong S; Wang T; Qi Y; Hu B; Fu H; Xie H; Zhou L; Chang Y; Zhu Y; Dai B; Zhang W; Xu J
Eur Urol; 2019 May; 75(5):752-763. PubMed ID: 30293904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
